Related Experiment Video
Updated: Feb 28, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Deciphering the Arterial and Venous Blood Bacterial DNA Profile: Pioneering Insights into Coronary Heart Disease
Mengru Liu1, Lin Zhao1, Tianli Li1
1Department of Integrative Medicine Cardiology, China-Japan Friendship Hospital, Beijing 100029, China.
Insights
This study explored bacterial profiles in coronary heart disease (CHD) patients, finding distinct microbial communities in arterial versus venous blood. Further research is needed to confirm these findings in larger patient groups.
Area of Science:
- Microbiology
- Cardiovascular Science
Background:
- Coronary heart disease (CHD) is a major global health concern.
- The gut microbiota is implicated in CHD development, but bacterial translocation remains difficult to quantify.
- Understanding bacterial presence in circulation is key to atherosclerosis research.
Purpose of the Study:
- To investigate systemic bacterial profiles in patients with coronary heart disease (CHD).
- To compare microbial diversity and richness between arterial and venous blood fractions.
- To explore the potential role of bacterial translocation in CHD pathogenesis.
Main Methods:
- 16S rRNA-based metagenomic analysis was performed on blood samples from 27 CHD patients.
- Microbial diversity was compared between plasma and serum.
- Differences in microbial richness were assessed across arterial and venous whole blood, plasma, and serum.
Main Results:
- Higher microbial diversity was observed in plasma compared to serum.
- Significant differences in microbial richness were found across various blood fractions (arterial/venous, whole blood/plasma/serum).
- Detected bacterial taxa were consistent with intestinal, oral, or skin microbiota origins.
Conclusions:
- Preliminary evidence suggests distinct bacterial profiles in arterial versus venous blood fractions of CHD patients.
- Findings indicate potential bacterial presence in systemic circulation.
- Larger, controlled studies are required to validate these preliminary results due to the small sample size and lack of a control group.
Background:
Coronary heart disease (CHD) is the leading cause of death and disability worldwide. The human microbiota, particularly gut bacteria, plays a role in the development of CHD. However, determining the contribution of gut bacteria translocation to systemic circulation in the progression of atherosclerosis remains challenging.
Methods And Results:
In this exploratory study, we conducted 16S rRNA-based metagenomic analysis to characterize systemic bacterial profiles in a cohort of 27 patients with CHD (9 with severe coronary artery stenosis and 18 with mild to moderate stenosis). We compared microbial diversity between arterial and venous blood and across different blood fractions. For the first time, we observed higher microbial diversity in plasma than in serum. We also identified differences in microbial richness among arterial whole blood, venous whole blood, arterial plasma, venous plasma, arterial serum, and venous serum, with 15, 22, 43, 10, 4, and 3 genera showing significant differences, respectively. Many of the detected blood taxa belonged to genera typically found in intestinal, oral, or skin microbiota, although their precise source cannot be determined from this study.
Conclusions:
Our study provides preliminary evidence of distinct bacterial profiles between arterial and venous blood fractions in patients with CHD, as determined by 16S rRNA sequencing. These findings should be interpreted with caution given the small sample size and the absence of a healthy control group, and they warrant confirmation in larger, controlled studies.
More Related Videos
13:07Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
08:51Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
Related Concept Videos
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Coronary Artery Disease III: Clinical Manifestations
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome III: Diagnostic Studies